Cargando…

Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution

The membrane-assisted isoform immunoassay (MAIIA) quantitates erythropoietin (EPO) isoforms as percentages of migrated isoforms (PMI). We evaluated the effect of recombinant human EPO (rhEPO) on the distribution of EPO isoforms in plasma in a randomized, placebo-controlled, double-blinded, cross-ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aachmann-Andersen, Niels Jacob, Just Christensen, Søren, Lisbjerg, Kristian, Oturai, Peter, Meinild-Lundby, Anne-Kristine, Holstein-Rathlou, Niels-Henrik, Lundby, Carsten, Vidiendal Olsen, Niels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204994/ https://www.ncbi.nlm.nih.gov/pubmed/25335123 http://dx.doi.org/10.1371/journal.pone.0110903

Ejemplares similares

Recombinant erythropoietin acutely decreases renal perfusion and decouples the renin‐angiotensin‐aldosterone system
por: Aachmann‐Andersen, Niels J., et al.
Publicado: (2018)

Evaluation of Functional Erythropoietin Receptor Status in Skeletal Muscle In Vivo: Acute and Prolonged Studies in Healthy Human Subjects
por: Christensen, Britt, et al.
Publicado: (2012)

Comparison of global cerebral blood flow measured by phase‐contrast mapping MRI with (15)O‐H(2)O positron emission tomography
por: Vestergaard, Mark Bitsch, et al.
Publicado: (2016)

Acute hypoxia increases the cerebral metabolic rate – a magnetic resonance imaging study
por: Vestergaard, Mark B, et al.
Publicado: (2015)

Erythropoietin Treatment Enhances Muscle Mitochondrial Capacity in Humans
por: Plenge, Ulla, et al.
Publicado: (2012)

Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure
por: Robach, Paul, et al.
Publicado: (2020)

Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivo
por: Christensen, Britt, et al.
Publicado: (2016)

Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial
por: Schmidt, Lejla Sjanic, et al.
Publicado: (2018)

Hematological Adaptations to Prolonged Heat Acclimation in Endurance-Trained Males
por: Oberholzer, Laura, et al.
Publicado: (2019)

Influence of Erythropoietin on Cognitive Performance during Experimental Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Randomized Cross-Over Trial
por: Kristensen, Peter Lommer, et al.
Publicado: (2013)

The Ergogenic Effect of Recombinant Human Erythropoietin on V̇O(2)max Depends on the Severity of Arterial Hypoxemia
por: Robach, Paul, et al.
Publicado: (2008)

Age‐dependent impairment of the erythropoietin response to reduced central venous pressure in HFpEF patients
por: Montero, David, et al.
Publicado: (2019)

Erythrocytes and Erythropoietin
por: Föller, Michael, et al.
Publicado: (2011)

Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma
por: Ribatti, D, et al.
Publicado: (2007)

Erythropoietin and the use of a transgenic model of erythropoietin-deficient mice
por: Pichon, Aurélien, et al.
Publicado: (2016)

A Comparative Analysis of Erythropoietin and Carbamoylated Erythropoietin Proteome Profiles
por: Tiwari, Neeraj K., et al.
Publicado: (2021)

New insights into erythropoietin and erythropoietin receptor in laryngeal cancer tissue
por: Vukelic, Jelena, et al.
Publicado: (2021)

EV-3, an endogenous human erythropoietin isoform with distinct functional relevance
por: Bonnas, Christel, et al.
Publicado: (2017)

Changes in metabolism but not myocellular signaling by training with CHO‐restriction in endurance athletes
por: Gejl, Kasper D., et al.
Publicado: (2018)

Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma
por: Ribatti, D, et al.
Publicado: (2007)

Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
por: Ye, Chen, et al.
Publicado: (2019)

Validation of a clinically applicable device for fast and accurate quantification of blood volume
por: Breenfeldt Andersen, Andreas, et al.
Publicado: (2023)

Erythropoietin: current status.
por: Bunn, H. F.
Publicado: (1990)

Erythropoietin and the Regulation of Erythropoiesis
por: Mc Phedran, Peter
Publicado: (1971)

Erythropoietin use and abuse
por: John, M. Joseph, et al.
Publicado: (2012)

Erythropoietin use in the newborn
por: Buonocore, Giuseppe
Publicado: (2014)

Erythropoietin and renal protection
por: Baradaran, Azar, et al.
Publicado: (2013)

Erythropoietin update 2011
por: Kowalczyk, Mariusz, et al.
Publicado: (2011)

Erythropoietin for Optic Neuritis
por: Foroozan, Rod
Publicado: (2019)

Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease
por: Khankin, Eliyahu V., et al.
Publicado: (2010)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
por: Hernández, Carolina Castillo, et al.
Publicado: (2017)

Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential
por: Liu, Xiaoqing, et al.
Publicado: (2020)

No effect of 10 weeks erythropoietin treatment on lipid oxidation in healthy men
por: Risikesan, Jeyanthini, et al.
Publicado: (2020)

Angiotensin II during Experimentally Simulated Central Hypovolemia
por: Jensen, Theo Walther, et al.
Publicado: (2016)

Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers
por: Christensen, Britt, et al.
Publicado: (2015)

Interacting information streams on the nephron arterial network
por: Marsh, Donald J., et al.
Publicado: (2023)

Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?
por: Gabutti, Luca, et al.
Publicado: (2011)

Diagnostic Performance of Erythropoietin and Erythropoietin Receptors Levels in Children with Attention Deficit Hyperactivity Disorder
por: Gungor, Meltem, et al.
Publicado: (2021)

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_jpjuk4psk1g8h3q1j46acqe9rl